Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016, Article ID 5715719, 12 pages
http://dx.doi.org/10.1155/2016/5715719
Research Article

Immunosuppression Induced by Chronic Inflammation and the Progression to Oral Squamous Cell Carcinoma

1Department of Periodontal & Oral Medicine, Beijing Stomatological Hospital, Capital Medical University, Beijing 100050, China
2Department of Stomatology, Beijing Tongren Hospital, Capital Medical University, Beijing 100005, China
3Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China
4Beijing Key Laboratory of Emerging Infectious Diseases, Beijing 100015, China

Received 11 July 2016; Accepted 10 November 2016

Academic Editor: Amedeo Amedei

Copyright © 2016 Yujuan Sun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Vayrynen and J. Bohm, “Inflammation and cancer—colorectal carcinoma as an example,” Duodecim, vol. 132, no. 2, pp. 137–144, 2016. View at Google Scholar
  2. M. Romano, F. De Francesco, L. Zarantonello et al., “From inflammation to cancer in inflammatory bowel disease: molecular perspectives,” Anticancer Research, vol. 36, no. 4, pp. 1447–1460, 2016. View at Google Scholar
  3. C. Li, M. Deng, J. Hu et al., “Chronic inflammation contributes to the development of hepatocellular carcinoma by decreasing miR-122 levels,” Oncotarget, vol. 7, no. 13, pp. 17021–17034, 2016. View at Publisher · View at Google Scholar
  4. S. M. Crusz and F. R. Balkwill, “Inflammation and cancer: advances and new agents,” Nature Reviews Clinical Oncology, vol. 12, no. 10, pp. 584–596, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Clevers, “At the crossroads of inflammation and cancer,” Cell, vol. 118, no. 6, pp. 671–674, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. K. J. O'Byrne and A. G. Dalgleish, “Chronic immune activation and inflammation as the cause of malignancy,” British Journal of Cancer, vol. 85, no. 4, pp. 473–483, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. I. Marigo, L. Dolcetti, P. Serafini, P. Zanovello, and V. Bronte, “Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells,” Immunological Reviews, vol. 222, no. 1, pp. 162–179, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. M. A. Morse, J. R. Hall, and J. M. D. Plate, “Countering tumor-induced immunosuppression during immunotherapy for pancreatic cancer,” Expert Opinion on Biological Therapy, vol. 9, no. 3, pp. 331–339, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Ostrand-Rosenberg, “Tolerance and immune suppression in the tumor microenvironment,” Cellular Immunology, vol. 299, pp. 23–29, 2016. View at Publisher · View at Google Scholar
  10. S. McGuire, “World cancer report 2014. Geneva, Switzerland: World Health Organization, international agency for research on cancer, WHO Press, 2015,” Advances in Nutrition, vol. 7, no. 2, pp. 418–419, 2016. View at Publisher · View at Google Scholar
  11. S. Warnakulasuriya, N. W. Johnson, and I. van der Waal, “Nomenclature and classification of potentially malignant disorders of the oral mucosa,” Journal of Oral Pathology and Medicine, vol. 36, no. 10, pp. 575–580, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. I. van der Waal, “Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management,” Oral Oncology, vol. 45, no. 4-5, pp. 317–323, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. I. van der Waal and C. Scully, “Oral cancer: comprehending the condition, causes, controversies, control and consequences. 4. Potentially malignant disorders of the oral and oropharyngeal mucosa,” Dental Update, vol. 38, no. 2, pp. 138–140, 2011. View at Google Scholar · View at Scopus
  14. M. Viguier, H. Bachelez, B. Poirier et al., “Peripheral and local human papillomavirus 16-specific CD8+ T-cell expansions characterize erosive oral lichen planus,” Journal of Investigative Dermatology, vol. 135, no. 2, pp. 418–424, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. I. Rodríguez-Núñez, A. Blanco-Carrión, A. G. García, and J. G. Rey, “Peripheral T-cell subsets in patients with reticular and atrophic-erosive oral lichen planus,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, vol. 91, no. 2, pp. 180–188, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. V. A. Triolo, “Nineteenth century foundations of cancer research advances in tumor pathology, nomenclature, and theories of oncogenesis,” Cancer Research, vol. 25, pp. 75–106, 1965. View at Google Scholar · View at Scopus
  17. B. W. Neville, D. D. Damm, C. M. Allen, and J. E. Bouquot, Oral & Maxillofacial Pathology, W.B. Saunders, Philadelphia, Pa, USA, 2nd edition, 2002.
  18. A. A. Khan, Z. Khan, and S. Warnakulasuriya, “Cancer-associated toll-like receptor modulation and insinuation in infection susceptibility: association or coincidence?” Annals of Oncology, vol. 27, no. 6, pp. 984–997, 2016. View at Publisher · View at Google Scholar
  19. F. Balkwill and A. Mantovani, “Inflammation and cancer: back to Virchow?” The Lancet, vol. 357, no. 9255, pp. 539–545, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. X.-A. Tao, J. Xia, X.-B. Chen et al., “FOXP3+ T regulatory cells in lesions of oral lichen planus correlated with disease activity,” Oral Diseases, vol. 16, no. 1, pp. 76–82, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. J. D. Fontenot, M. A. Gavin, and A. Y. Rudensky, “Foxp3 programs the development and function of CD4+CD25+ regulatory T cells,” Nature Immunology, vol. 4, no. 4, pp. 330–336, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. T. H. Gasparoto, T. S. de Souza Malaspina, L. Benevides et al., “Patients with oral squamous cell carcinoma are characterized by increased frequency of suppressive regulatory T cells in the blood and tumor microenvironment,” Cancer Immunology, Immunotherapy, vol. 59, no. 6, pp. 819–828, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. W.-W. Lin and M. Karin, “A cytokine-mediated link between innate immunity, inflammation, and cancer,” The Journal of Clinical Investigation, vol. 117, no. 5, pp. 1175–1183, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Ding, J. Zeng, H. Sroussi et al., “Interactions between Golli-MBP and Th1/Th2 cytokines in patients with oral lichen planus,” Oral Diseases, vol. 20, no. 2, pp. 205–211, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Khan, C. S. Farah, N. W. Savage, L. J. Walsh, D. J. Harbrow, and P. B. Sugerman, “Th1 cytokines in oral lichen planus,” Journal of Oral Pathology and Medicine, vol. 32, no. 2, pp. 77–83, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. S. W. Chandler, C. H. Rassekh, S. M. Rodman, and B. S. Ducatman, “Immunohistochemical localization of interleukin-10 in human oral and pharyngeal carcinomas,” Laryngoscope, vol. 112, no. 5, pp. 808–815, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. M. R. I. Young, B. W. Neville, A. C. Chi, D. M. R. Lathers, M. B. Gillespie, and T. A. Day, “Autocrine motility-stimulatory pathways of oral premalignant lesion cells,” Clinical and Experimental Metastasis, vol. 24, no. 2, pp. 131–139, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. J. N. Myers, S. Yasumura, Y. Suminami et al., “Growth stimulation of human head and neck squamous cell carcinoma cell lines by interleukin 4,” Clinical Cancer Research, vol. 2, no. 1, pp. 127–135, 1996. View at Google Scholar · View at Scopus
  29. T. Schüler, Z. Qin, S. Ibe, N. Noben-Trauth, and T. Blankenstein, “T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice,” The Journal of Experimental Medicine, vol. 189, no. 5, pp. 803–810, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. M. V. M. de Oliveira, C. A. D. C. Fraga, R. S. Gomez, and A. M. B. D. Paula, “Immunohistochemical expression of interleukin-4, -6, -8, and -12 in inflammatory cells in surrounding invasive front of oral squamous cell carcinoma,” Head & Neck, vol. 31, no. 11, pp. 1439–1446, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. P. B. Sugerman, N. W. Savage, L. J. Walsh et al., “The pathogenesis of oral lichen planus,” Critical Reviews in Oral Biology and Medicine, vol. 13, no. 4, pp. 350–365, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Youngnak-Piboonratanakit, K. Dhanuthai, K. Thongprasom et al., “Expression of ifn-γ before and after treatment of oral lichen planus with 0.1% fluocinolone acetonide in orabase,” Journal of Oral Pathology and Medicine, vol. 38, no. 9, pp. 689–694, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. J.-H. Heimdal, C. Olsnes, J. Olofsson, and H. J. Aarstad, “Monocyte and monocyte-derived macrophage secretion of MCP-1 in co-culture with autologous malignant and benign control fragment spheroids,” Cancer Immunology, Immunotherapy, vol. 50, no. 6, pp. 300–306, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Yoshimura, N. Yuhki, S. K. Moore, E. Appella, M. I. Lerman, and E. J. Leonard, “Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE,” FEBS Letters, vol. 244, no. 2, pp. 487–493, 1989. View at Publisher · View at Google Scholar
  35. H. Saji, M. Koike, T. Yamori et al., “Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma,” Cancer, vol. 92, no. 5, pp. 1085–1091, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Gupta, K. Cerosaletti, and S. A. Long, “Renegade homeostatic cytokine responses in T1D: drivers of regulatory/effector T cell imbalance,” Clinical Immunology, vol. 151, no. 2, pp. 146–154, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Tucci, S. Stucci, S. Strippoli, and F. Silvestris, “Cytokine overproduction, T-cell activation, and defective T-regulatory functions promote nephritis in systemic lupus erythematosus,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 457146, 6 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. E. Van Overmeire, D. Laoui, J. Keirsse, J. A. Van Ginderachter, and A. Sarukhan, “Mechanisms driving macrophage diversity and specialization in distinct tumor microenvironments and parallelisms with other tissues,” Frontiers in Immunology, vol. 5, article 127, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. S. V. Tarasenko, A. I. Shatokhin, K. T. Umbetova, and M. A. Stepanov, “T-cells immunity in oral lichen planus pathogenesis,” Stomatologiia, vol. 93, no. 1, pp. 60–63, 2014. View at Google Scholar · View at Scopus
  40. S. Ramanathan and N. Jagannathan, “Tumor associated macrophage: a review on the phenotypes, traits and functions,” Iranian Journal of Cancer Prevention, vol. 7, no. 1, pp. 1–8, 2014. View at Google Scholar · View at Scopus
  41. D. Laoui, E. Van Overmeire, P. De Baetselier, J. A. Van Ginderachter, and G. Raes, “Functional relationship between tumor-associated macrophages and macrophage colony-stimulating factor as contributors to cancer progression,” Frontiers in Immunology, vol. 5, article 489, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. T. L. Whiteside, “Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression?” Cancer Immunology, Immunotherapy, vol. 63, no. 1, pp. 67–72, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. P. A. Savage, S. Malchow, and D. S. Leventhal, “Basic principles of tumor-associated regulatory T cell biology,” Trends in Immunology, vol. 34, no. 1, pp. 33–40, 2013. View at Publisher · View at Google Scholar · View at Scopus